Key strategic initiatives for 2017
Our strategy is to provide wider and cost-effective access to radiation treatment through a ground-breaking proton therapy system with superior clinical benefits for cancer patients.
System development and partner negotiations
We intend to sign partnerships agreements with the key manufacturers and collaborators associated throughout the development of our LIGHT machine.
We will continue to build our expert team. A number of important appointments were already made since the beginning of 2014. Our people are focused on developing the first accelerator and operational LIGHT system as safely and quickly as possible.
New hospital contracts
Because cancer is a global phenomenon with no geographic boundaries, we will continue discussions with existing and new parties, both in the United States and in other regions of the world.